Healthcare IT News January 16, 2018
Continuous funding and partnerships – along with the potential for blockchain-based efforts to reduce the counterfeiting of drugs – are also changing the landscape a new report finds.
Pharmacy supply chain management to reduce drug counterfeiting were highlighted in the study.
The healthcare supply chain management market should reach $2.31 billion by 2022, up from $1.55 billion in 2017, according to a new study from ReportsnReports.com.
This growth will be driven by increased pressure on healthcare providers to improve operational efficiency and profitability, researchers said.
Key factors include the emergence of cloud-based systems, implementation of the unique device identification initiative by the U.S. Food and Drug Administration, the adoption of the GS1 System of standards in the healthcare industry globally...